0371-57123510
contact@kejianyi.cn
Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery

ISSN1746-0441影响因子4.9自引率2.00%研究类文章占比25.64%中科院分区医学 2区
h-index50年文章数78OA文章占比15.56%JCI期刊引文指标0.72JCR分区Q2
期刊简称
EXPERT OPIN DRUG DIS
期刊简介
Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.The Editors welcome:Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biologyDrug Case Histories examining the steps involved in the preclinical and clinical development of a particular drugThe audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.
期刊官网
http://www.tandfonline.com/toc/iedc20/current
投稿网址
https://mc.manuscriptcentral.com/eodc
通讯方式
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
出版商
Informa Healthcare
出版周期
Bimonthly
语言
English
创刊时间
2006
所属国家/地区
ENGLAND
涉及的研究方向
医学-药学
是否OA
No
PubMed Central链接
http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1746-0441%5BISSN%5D
中国科学院《国际期刊预警名单(试行)》名单
2025年03月发布的2025版:不在预警名单中
2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
2025年中国科学院期刊分区
大类学科小类学科Top期刊综述期刊
医学2区
PHARMACOLOGY & PHARMACY药学2区
Cite Score
Cite ScoreSJRSNIP排名
10.601.1951.071
学科分区排名
大类:Pharmacology, Toxicology and Pharmaceutics小类:Drug DiscoveryQ120 / 156
历年JCR分区
历年影响因子
历年自引率
历年文章数量